fanta.bio Sample: CNhs11995
15713 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1131 / 9452 (12.0%) | 252 / 94520 (0.3%) | −324.0 | −324.0 | 44.88 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1617 / 9452 (17.1%) | 449 / 94520 (0.5%) | −324.0 | −324.0 | 36.01 |
| HIF1A SRX11007095 | HK-2 Kidney | 1484 / 9452 (15.7%) | 697 / 94520 (0.7%) | −324.0 | −324.0 | 21.29 |
| SCML2 SRX644728 | 293 Kidney | 962 / 9452 (10.2%) | 527 / 94520 (0.6%) | −324.0 | −324.0 | 18.25 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1076 / 9452 (11.4%) | 596 / 94520 (0.6%) | −324.0 | −324.0 | 18.05 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1526 / 9452 (16.1%) | 883 / 94520 (0.9%) | −324.0 | −324.0 | 17.28 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1451 / 9452 (15.4%) | 870 / 94520 (0.9%) | −324.0 | −324.0 | 16.68 |
| BRD4 SRX9419935 | BT-474 Breast | 2445 / 9452 (25.9%) | 1861 / 94520 (2.0%) | −324.0 | −324.0 | 13.14 |
| MED1 SRX9419945 | BT-474 Breast | 2452 / 9452 (25.9%) | 1885 / 94520 (2.0%) | −324.0 | −324.0 | 13.01 |
| MED1 SRX9419944 | BT-474 Breast | 2395 / 9452 (25.3%) | 1864 / 94520 (2.0%) | −324.0 | −324.0 | 12.85 |
| MED1 SRX9419947 | BT-474 Breast | 2421 / 9452 (25.6%) | 1921 / 94520 (2.0%) | −324.0 | −324.0 | 12.60 |
| MED1 SRX9419946 | BT-474 Breast | 2470 / 9452 (26.1%) | 1961 / 94520 (2.1%) | −324.0 | −324.0 | 12.60 |
| BRD4 SRX9419937 | BT-474 Breast | 2421 / 9452 (25.6%) | 1926 / 94520 (2.0%) | −324.0 | −324.0 | 12.57 |
| BRD4 SRX9419936 | BT-474 Breast | 2483 / 9452 (26.3%) | 1978 / 94520 (2.1%) | −324.0 | −324.0 | 12.55 |
| BRD4 SRX9419938 | BT-474 Breast | 2457 / 9452 (26.0%) | 1971 / 94520 (2.1%) | −324.0 | −324.0 | 12.47 |
| FOXP1 SRX736067 | LNCAP Prostate | 1043 / 9452 (11.0%) | 838 / 94520 (0.9%) | −324.0 | −324.0 | 12.45 |
| BRD4 SRX736201 | 90-8TL Neural | 3983 / 9452 (42.1%) | 4104 / 94520 (4.3%) | −324.0 | −324.0 | 9.71 |
| EZH2 SRX2146136 | LNCAP Prostate | 4894 / 9452 (51.8%) | 5260 / 94520 (5.6%) | −324.0 | −324.0 | 9.30 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1194 / 9452 (12.6%) | 1693 / 94520 (1.8%) | −324.0 | −324.0 | 7.05 |
| 5-mC SRX882965 | LNCAP Prostate | 1960 / 9452 (20.7%) | 6645 / 94520 (7.0%) | −324.0 | −324.0 | 2.95 |
| 5-mC SRX882970 | LNCAP Prostate | 2401 / 9452 (25.4%) | 8511 / 94520 (9.0%) | −324.0 | −324.0 | 2.82 |
| 5-mC SRX882968 | LNCAP Prostate | 2362 / 9452 (25.0%) | 8466 / 94520 (9.0%) | −324.0 | −324.0 | 2.79 |
| RUNX1 SRX2513054 | 293 Kidney | 2549 / 9452 (27.0%) | 9981 / 94520 (10.6%) | −324.0 | −324.0 | 2.55 |
| AGO2 SRX4708039 | Hep G2 Liver | 1476 / 9452 (15.6%) | 4252 / 94520 (4.5%) | −320.6 | −317.5 | 3.47 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 621 / 9452 (6.6%) | 573 / 94520 (0.6%) | −319.8 | −316.7 | 10.84 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1670 / 9452 (17.7%) | 5395 / 94520 (5.7%) | −316.0 | −312.9 | 3.10 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1176 / 9452 (12.4%) | 2960 / 94520 (3.1%) | −293.9 | −290.8 | 3.97 |
| CIC SRX13262055 | Astrocytes Neural | 2246 / 9452 (23.8%) | 9477 / 94520 (10.0%) | −287.2 | −284.1 | 2.37 |
| MYH11 SRX265221 | ME-1 Blood | 524 / 9452 (5.5%) | 446 / 94520 (0.5%) | −280.0 | −276.9 | 11.75 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 377 / 9452 (4.0%) | 136 / 94520 (0.1%) | −273.6 | −270.5 | 27.72 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 485 / 9452 (5.1%) | 370 / 94520 (0.4%) | −272.2 | −269.2 | 13.11 |
| TP53 SRX19538279 | Osteoblasts Bone | 398 / 9452 (4.2%) | 191 / 94520 (0.2%) | −265.7 | −262.7 | 20.84 |
| PBX4 SRX2731658 | PC-3 Prostate | 411 / 9452 (4.3%) | 14886 / 94520 (15.7%) | −251.3 | −248.3 | 0.28 |
| TRP47 SRX4548329 | THP-1 Blood | 1912 / 9452 (20.2%) | 7851 / 94520 (8.3%) | −251.2 | −248.2 | 2.44 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1326 / 9452 (14.0%) | 4356 / 94520 (4.6%) | −240.2 | −237.2 | 3.04 |
| IRF3 SRX11453858 | Hep G2 Liver | 283 / 9452 (3.0%) | 48 / 94520 (0.1%) | −240.0 | −237.1 | 58.96 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 461 / 9452 (4.9%) | 417 / 94520 (0.4%) | −238.8 | −235.8 | 11.06 |
| Epitope tags SRX10549776 | K-562 Blood | 1053 / 9452 (11.1%) | 2935 / 94520 (3.1%) | −232.8 | −229.9 | 3.59 |
| TP53 SRX19538274 | U2OS Bone | 321 / 9452 (3.4%) | 133 / 94520 (0.1%) | −223.9 | −221.0 | 24.14 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 873 / 9452 (9.2%) | 2137 / 94520 (2.3%) | −221.6 | −218.7 | 4.09 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1348 / 9452 (14.3%) | 4759 / 94520 (5.0%) | −219.9 | −217.0 | 2.83 |
| TP53 SRX19538268 | U2OS Bone | 317 / 9452 (3.4%) | 138 / 94520 (0.1%) | −217.9 | −215.0 | 22.97 |
| TP53 SRX19538276 | U2OS Bone | 313 / 9452 (3.3%) | 133 / 94520 (0.1%) | −216.7 | −213.8 | 23.53 |
| SREBF2 SRX5359048 | HCC70 Breast | 1259 / 9452 (13.3%) | 4277 / 94520 (4.5%) | −216.5 | −213.6 | 2.94 |
| TP53 SRX19538280 | Osteoblasts Bone | 315 / 9452 (3.3%) | 142 / 94520 (0.2%) | −214.2 | −211.3 | 22.18 |
| TP53 SRX19538273 | U2OS Bone | 293 / 9452 (3.1%) | 110 / 94520 (0.1%) | −210.1 | −207.2 | 26.64 |
| MITF SRX1555436 | 501A Epidermis | 1418 / 9452 (15.0%) | 5362 / 94520 (5.7%) | −208.1 | −205.2 | 2.64 |
| TP53 SRX19538267 | U2OS Bone | 293 / 9452 (3.1%) | 114 / 94520 (0.1%) | −208.0 | −205.2 | 25.70 |
| BRD4 SRX736204 | 90-8TL Neural | 734 / 9452 (7.8%) | 1623 / 94520 (1.7%) | −205.4 | −202.6 | 4.52 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1199 / 9452 (12.7%) | 4074 / 94520 (4.3%) | −205.4 | −202.6 | 2.94 |
| TP53 SRX19538281 | Osteoblasts Bone | 336 / 9452 (3.6%) | 208 / 94520 (0.2%) | −204.9 | −202.1 | 16.15 |
| TP53 SRX19538275 | U2OS Bone | 296 / 9452 (3.1%) | 126 / 94520 (0.1%) | −204.8 | −202.0 | 23.49 |
| TP53 SRX19538269 | U2OS Bone | 362 / 9452 (3.8%) | 270 / 94520 (0.3%) | −204.7 | −201.9 | 13.41 |
| IRF3 SRX11453861 | Hep G2 Liver | 249 / 9452 (2.6%) | 52 / 94520 (0.1%) | −203.8 | −201.0 | 47.88 |
| BMI1 SRX7196721 | SF8628 Neural | 1251 / 9452 (13.2%) | 4410 / 94520 (4.7%) | −203.3 | −200.5 | 2.84 |
| KAT6A SRX20971022 | Fibroblasts Others | 236 / 9452 (2.5%) | 37 / 94520 (0.0%) | −202.5 | −199.8 | 63.78 |
| YAP1 SRX757325 | H2052 Lung | 289 / 9452 (3.1%) | 11397 / 94520 (12.1%) | −202.2 | −199.4 | 0.25 |
| MECOM SRX23677885 | HNT-34 Blood | 1256 / 9452 (13.3%) | 4540 / 94520 (4.8%) | −196.4 | −193.6 | 2.77 |
| AGO2 SRX6783958 | Hep G2 Liver | 895 / 9452 (9.5%) | 2503 / 94520 (2.6%) | −195.6 | −192.8 | 3.58 |
| AGO2 SRX6783957 | Hep G2 Liver | 895 / 9452 (9.5%) | 2508 / 94520 (2.7%) | −195.1 | −192.4 | 3.57 |
| RUNX1 SRX2014504 | Jurkat Blood | 1666 / 9452 (17.6%) | 7246 / 94520 (7.7%) | −192.8 | −190.1 | 2.30 |
| MECOM SRX23677896 | HNT-34 Blood | 1475 / 9452 (15.6%) | 5993 / 94520 (6.3%) | −191.8 | −189.1 | 2.46 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1325 / 9452 (14.0%) | 5061 / 94520 (5.4%) | −190.0 | −187.3 | 2.62 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1339 / 9452 (14.2%) | 5166 / 94520 (5.5%) | −189.1 | −186.4 | 2.59 |
| TET2 SRX2014505 | Jurkat Blood | 1799 / 9452 (19.0%) | 8239 / 94520 (8.7%) | −189.0 | −186.3 | 2.18 |
| MECOM SRX23677884 | HNT-34 Blood | 1226 / 9452 (13.0%) | 4476 / 94520 (4.7%) | −188.4 | −185.7 | 2.74 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 438 / 9452 (4.6%) | 553 / 94520 (0.6%) | −188.3 | −185.6 | 7.92 |
| MECOM SRX23677897 | HNT-34 Blood | 1423 / 9452 (15.1%) | 5742 / 94520 (6.1%) | −186.7 | −184.0 | 2.48 |
| AR SRX10820653 | LNCAP Prostate | 281 / 9452 (3.0%) | 137 / 94520 (0.1%) | −186.3 | −183.7 | 20.51 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 982 / 9452 (10.4%) | 3080 / 94520 (3.3%) | −186.2 | −183.5 | 3.19 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 437 / 9452 (4.6%) | 564 / 94520 (0.6%) | −185.2 | −182.6 | 7.75 |
| YAP1 SRX757326 | H2052 Lung | 254 / 9452 (2.7%) | 10241 / 94520 (10.8%) | −183.5 | −180.9 | 0.25 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1252 / 9452 (13.2%) | 4717 / 94520 (5.0%) | −183.0 | −180.3 | 2.65 |
| TP53 SRX19538270 | U2OS Bone | 333 / 9452 (3.5%) | 267 / 94520 (0.3%) | −182.2 | −179.6 | 12.47 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1272 / 9452 (13.5%) | 4856 / 94520 (5.1%) | −182.2 | −179.5 | 2.62 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1105 / 9452 (11.7%) | 3854 / 94520 (4.1%) | −181.0 | −178.4 | 2.87 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1246 / 9452 (13.2%) | 4723 / 94520 (5.0%) | −180.3 | −177.7 | 2.64 |
| TP53 SRX19538271 | U2OS Bone | 469 / 9452 (5.0%) | 706 / 94520 (0.7%) | −179.3 | −176.7 | 6.64 |
| HIF1A SRX20663235 | HK-2 Kidney | 307 / 9452 (3.2%) | 217 / 94520 (0.2%) | −177.5 | −174.8 | 14.15 |
| FOXA1 SRX4815198 | MCF-7 Breast | 484 / 9452 (5.1%) | 13652 / 94520 (14.4%) | −172.7 | −170.1 | 0.35 |
| AR SRX10820651 | LNCAP Prostate | 285 / 9452 (3.0%) | 202 / 94520 (0.2%) | −164.5 | −161.9 | 14.11 |
| Epitope tags SRX2255894 | 293 Kidney | 953 / 9452 (10.1%) | 3241 / 94520 (3.4%) | −160.9 | −158.3 | 2.94 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 308 / 9452 (3.3%) | 10486 / 94520 (11.1%) | −160.9 | −158.3 | 0.29 |
| RORC SRX5359053 | HCC70 Breast | 883 / 9452 (9.3%) | 2846 / 94520 (3.0%) | −160.5 | −157.9 | 3.10 |
| FOXA1 SRX4815197 | MCF-7 Breast | 350 / 9452 (3.7%) | 11154 / 94520 (11.8%) | −160.3 | −157.8 | 0.31 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1266 / 9452 (13.4%) | 5204 / 94520 (5.5%) | −159.0 | −156.4 | 2.43 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 211 / 9452 (2.2%) | 68 / 94520 (0.1%) | −157.4 | −154.8 | 31.03 |
| TP53 SRX19538282 | Osteoblasts Bone | 284 / 9452 (3.0%) | 222 / 94520 (0.2%) | −157.1 | −154.6 | 12.79 |
| RORC SRX5359052 | HCC70 Breast | 900 / 9452 (9.5%) | 3002 / 94520 (3.2%) | −155.9 | −153.3 | 3.00 |
| ERG SRX063922 | K-562 Blood | 1055 / 9452 (11.2%) | 3943 / 94520 (4.2%) | −154.6 | −152.0 | 2.68 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 351 / 9452 (3.7%) | 10930 / 94520 (11.6%) | −152.7 | −150.1 | 0.32 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 532 / 9452 (5.6%) | 13682 / 94520 (14.5%) | −152.4 | −149.9 | 0.39 |
| MethylCap SRX014767 | NB-4 Blood | 1164 / 9452 (12.3%) | 4664 / 94520 (4.9%) | −152.1 | −149.5 | 2.50 |
| FOS SRX150477 | MCF 10A Breast | 364 / 9452 (3.9%) | 11110 / 94520 (11.8%) | −152.0 | −149.4 | 0.33 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 452 / 9452 (4.8%) | 805 / 94520 (0.9%) | −151.9 | −149.4 | 5.61 |
| GATA3 SRX190194 | SK-N-SH Neural | 350 / 9452 (3.7%) | 10883 / 94520 (11.5%) | −151.8 | −149.3 | 0.32 |
| FOXA1 SRX176862 | MCF-7 Breast | 170 / 9452 (1.8%) | 7769 / 94520 (8.2%) | −151.1 | −148.6 | 0.22 |
| FOXA1 SRX176863 | MCF-7 Breast | 155 / 9452 (1.6%) | 7453 / 94520 (7.9%) | −150.0 | −147.5 | 0.21 |
| BRPF3 SRX796085 | RKO Digestive tract | 705 / 9452 (7.5%) | 2002 / 94520 (2.1%) | −150.0 | −147.4 | 3.52 |
| KAT7 SRX101303 | RKO Digestive tract | 870 / 9452 (9.2%) | 2906 / 94520 (3.1%) | −150.0 | −147.4 | 2.99 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1133 / 9452 (12.0%) | 4516 / 94520 (4.8%) | −149.3 | −146.8 | 2.51 |
| BRD1 SRX286203 | RKO Digestive tract | 768 / 9452 (8.1%) | 2359 / 94520 (2.5%) | −148.2 | −145.7 | 3.26 |
| SS18 SRX3468047 | Fibroblasts Others | 391 / 9452 (4.1%) | 11377 / 94520 (12.0%) | −147.1 | −144.6 | 0.34 |
| BRPF3 SRX796084 | RKO Digestive tract | 960 / 9452 (10.2%) | 3492 / 94520 (3.7%) | −146.2 | −143.7 | 2.75 |
| BRPF3 SRX796086 | RKO Digestive tract | 923 / 9452 (9.8%) | 3279 / 94520 (3.5%) | −145.5 | −143.0 | 2.81 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 560 / 9452 (5.9%) | 1328 / 94520 (1.4%) | −145.2 | −142.7 | 4.22 |
| FOXA1 SRX3931044 | MCF-7 Breast | 330 / 9452 (3.5%) | 10309 / 94520 (10.9%) | −143.9 | −141.5 | 0.32 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1329 / 9452 (14.1%) | 5914 / 94520 (6.3%) | −143.5 | −141.0 | 2.25 |
| FOS SRX150478 | MCF 10A Breast | 400 / 9452 (4.2%) | 11339 / 94520 (12.0%) | −141.8 | −139.4 | 0.35 |
| TP53 SRX19538272 | U2OS Bone | 393 / 9452 (4.2%) | 639 / 94520 (0.7%) | −141.7 | −139.3 | 6.15 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 550 / 9452 (5.8%) | 13556 / 94520 (14.3%) | −141.3 | −138.8 | 0.41 |
| ERG SRX063921 | K-562 Blood | 978 / 9452 (10.3%) | 3682 / 94520 (3.9%) | −140.8 | −138.3 | 2.66 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 297 / 9452 (3.1%) | 9619 / 94520 (10.2%) | −139.1 | −136.6 | 0.31 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 191 / 9452 (2.0%) | 69 / 94520 (0.1%) | −138.4 | −135.9 | 27.68 |
| ZFX SRX7805372 | 293 Kidney | 991 / 9452 (10.5%) | 3835 / 94520 (4.1%) | −136.4 | −133.9 | 2.58 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 430 / 9452 (4.5%) | 821 / 94520 (0.9%) | −136.3 | −133.8 | 5.24 |
| RELA SRX2207673 | HUVEC Cardiovascular | 607 / 9452 (6.4%) | 14150 / 94520 (15.0%) | −135.2 | −132.8 | 0.43 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 335 / 9452 (3.5%) | 10105 / 94520 (10.7%) | −135.2 | −132.7 | 0.33 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 89 / 9452 (0.9%) | 5692 / 94520 (6.0%) | −134.7 | −132.3 | 0.16 |
| FOXA1 SRX1161177 | MCF-7 Breast | 141 / 9452 (1.5%) | 6700 / 94520 (7.1%) | −133.1 | −130.7 | 0.21 |
| Epitope tags SRX10549778 | K-562 Blood | 729 / 9452 (7.7%) | 2337 / 94520 (2.5%) | −132.5 | −130.1 | 3.12 |
| FOXL2 SRX6957431 | KGN Gonad | 369 / 9452 (3.9%) | 10512 / 94520 (11.1%) | −131.4 | −129.0 | 0.35 |
| GRHL3 SRX2582162 | NHEK Epidermis | 704 / 9452 (7.4%) | 2213 / 94520 (2.3%) | −131.3 | −128.9 | 3.18 |
| FOS SRX4192880 | MCF 10A Breast | 275 / 9452 (2.9%) | 9010 / 94520 (9.5%) | −131.3 | −128.9 | 0.31 |
| MECOM SRX23677890 | HNT-34 Blood | 1134 / 9452 (12.0%) | 4852 / 94520 (5.1%) | −130.8 | −128.4 | 2.34 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 394 / 9452 (4.2%) | 10844 / 94520 (11.5%) | −129.9 | −127.4 | 0.36 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 411 / 9452 (4.3%) | 11101 / 94520 (11.7%) | −129.8 | −127.4 | 0.37 |
| SREBF2 SRX5359049 | HCC70 Breast | 782 / 9452 (8.3%) | 2680 / 94520 (2.8%) | −129.3 | −126.9 | 2.92 |
| STAT5B SRX831881 | CD8+ T cells Blood | 203 / 9452 (2.1%) | 112 / 94520 (0.1%) | −129.1 | −126.7 | 18.13 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 370 / 9452 (3.9%) | 631 / 94520 (0.7%) | −128.6 | −126.1 | 5.86 |
| JUN SRX17561461 | LPS141 Adipocyte | 221 / 9452 (2.3%) | 8003 / 94520 (8.5%) | −128.3 | −125.9 | 0.28 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 362 / 9452 (3.8%) | 10288 / 94520 (10.9%) | −128.0 | −125.6 | 0.35 |
| JUNB SRX8488073 | SUM 229PE Breast | 305 / 9452 (3.2%) | 9383 / 94520 (9.9%) | −127.7 | −125.4 | 0.33 |
| RELA SRX2207672 | HUVEC Cardiovascular | 677 / 9452 (7.2%) | 14841 / 94520 (15.7%) | −127.7 | −125.3 | 0.46 |
| FOXA1 SRX371482 | MCF-7 Breast | 237 / 9452 (2.5%) | 8255 / 94520 (8.7%) | −127.6 | −125.2 | 0.29 |
| TCF12 SRX190356 | SK-N-SH Neural | 466 / 9452 (4.9%) | 11816 / 94520 (12.5%) | −126.9 | −124.5 | 0.39 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 560 / 9452 (5.9%) | 13145 / 94520 (13.9%) | −126.1 | −123.7 | 0.43 |
| FOXA1 SRX371483 | MCF-7 Breast | 179 / 9452 (1.9%) | 7194 / 94520 (7.6%) | −125.8 | −123.5 | 0.25 |
| BMI1 SRX644729 | 293 Kidney | 188 / 9452 (2.0%) | 90 / 94520 (0.1%) | −125.4 | −123.1 | 20.89 |
| MECOM SRX23677891 | HNT-34 Blood | 1113 / 9452 (11.8%) | 4844 / 94520 (5.1%) | −124.1 | −121.7 | 2.30 |
| FOXA1 SRX1161173 | MCF-7 Breast | 113 / 9452 (1.2%) | 5892 / 94520 (6.2%) | −124.1 | −121.7 | 0.19 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1022 / 9452 (10.8%) | 4260 / 94520 (4.5%) | −123.3 | −120.9 | 2.40 |
| YAP1 SRX5718140 | 293 Kidney | 280 / 9452 (3.0%) | 8822 / 94520 (9.3%) | −123.1 | −120.7 | 0.32 |
| GATA3 SRX190239 | MCF-7 Breast | 238 / 9452 (2.5%) | 8112 / 94520 (8.6%) | −122.5 | −120.2 | 0.29 |
| FOXA1 SRX1161175 | MCF-7 Breast | 105 / 9452 (1.1%) | 5675 / 94520 (6.0%) | −122.0 | −119.6 | 0.19 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 221 / 9452 (2.3%) | 174 / 94520 (0.2%) | −121.9 | −119.5 | 12.70 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1152 / 9452 (12.2%) | 5159 / 94520 (5.5%) | −121.4 | −119.1 | 2.23 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 704 / 9452 (7.4%) | 2351 / 94520 (2.5%) | −120.6 | −118.3 | 2.99 |
| GATA3 SRX176864 | MCF-7 Breast | 103 / 9452 (1.1%) | 5588 / 94520 (5.9%) | −120.3 | −117.9 | 0.18 |
| MethylCap SRX014766 | NB-4 Blood | 992 / 9452 (10.5%) | 4135 / 94520 (4.4%) | −119.4 | −117.1 | 2.40 |
| Epitope tags SRX2867680 | 293 Kidney | 1269 / 9452 (13.4%) | 6036 / 94520 (6.4%) | −118.2 | −115.9 | 2.10 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 210 / 9452 (2.2%) | 7485 / 94520 (7.9%) | −117.8 | −115.4 | 0.28 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 767 / 9452 (8.1%) | 2761 / 94520 (2.9%) | −117.6 | −115.2 | 2.78 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 516 / 9452 (5.5%) | 12184 / 94520 (12.9%) | −117.1 | −114.8 | 0.42 |
| ING5 SRX286202 | RKO Digestive tract | 787 / 9452 (8.3%) | 2889 / 94520 (3.1%) | −117.1 | −114.7 | 2.72 |
| SMARCA2 SRX8119677 | MeT-5A Others | 281 / 9452 (3.0%) | 8643 / 94520 (9.1%) | −117.0 | −114.7 | 0.33 |
| CHD6 SRX17709200 | C4-2 Prostate | 965 / 9452 (10.2%) | 4005 / 94520 (4.2%) | −116.9 | −114.6 | 2.41 |
| FOXA1 SRX11222441 | MCF-7 Breast | 114 / 9452 (1.2%) | 5696 / 94520 (6.0%) | −116.4 | −114.1 | 0.20 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 153 / 9452 (1.6%) | 6424 / 94520 (6.8%) | −116.0 | −113.7 | 0.24 |
| RBFOX2 SRX4708082 | K-562 Blood | 1414 / 9452 (15.0%) | 7132 / 94520 (7.5%) | −115.7 | −113.4 | 1.98 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 206 / 9452 (2.2%) | 7350 / 94520 (7.8%) | −115.5 | −113.2 | 0.28 |
| FOXA1 SRX3923514 | MCF-7 Breast | 163 / 9452 (1.7%) | 6580 / 94520 (7.0%) | −115.2 | −112.9 | 0.25 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 166 / 9452 (1.8%) | 6632 / 94520 (7.0%) | −115.0 | −112.7 | 0.25 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 287 / 9452 (3.0%) | 8663 / 94520 (9.2%) | −114.8 | −112.5 | 0.33 |
| LEO1 SRX1873456 | SEM Blood | 875 / 9452 (9.3%) | 3467 / 94520 (3.7%) | −114.8 | −112.5 | 2.52 |
| ESR1 SRX7624157 | MCF-7 Breast | 477 / 9452 (5.0%) | 11519 / 94520 (12.2%) | −114.3 | −112.0 | 0.41 |
| FOS SRX150517 | MCF 10A Breast | 309 / 9452 (3.3%) | 8990 / 94520 (9.5%) | −114.1 | −111.8 | 0.34 |
| FOXA1 SRX1161176 | MCF-7 Breast | 159 / 9452 (1.7%) | 6463 / 94520 (6.8%) | −113.6 | −111.3 | 0.25 |
| SMARCA4 SRX5212362 | Mel270 Others | 302 / 9452 (3.2%) | 8851 / 94520 (9.4%) | −113.3 | −111.0 | 0.34 |
| JUNB SRX8488074 | SUM 229PE Breast | 228 / 9452 (2.4%) | 7629 / 94520 (8.1%) | −112.7 | −110.4 | 0.30 |
| FOXA1 SRX371481 | MCF-7 Breast | 182 / 9452 (1.9%) | 6841 / 94520 (7.2%) | −112.7 | −110.4 | 0.27 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 329 / 9452 (3.5%) | 572 / 94520 (0.6%) | −112.5 | −110.2 | 5.75 |
| GATA3 SRX5057632 | MCF-7 Breast | 96 / 9452 (1.0%) | 5205 / 94520 (5.5%) | −111.9 | −109.6 | 0.18 |
| ESR1 SRX371478 | MCF-7 Breast | 229 / 9452 (2.4%) | 7619 / 94520 (8.1%) | −111.8 | −109.5 | 0.30 |
| SSRP1 SRX3436567 | HT-1080 Bone | 263 / 9452 (2.8%) | 339 / 94520 (0.4%) | −111.3 | −109.0 | 7.76 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 266 / 9452 (2.8%) | 8203 / 94520 (8.7%) | −111.2 | −108.9 | 0.32 |
| EP300 SRX2671813 | Fibroblasts Others | 133 / 9452 (1.4%) | 5901 / 94520 (6.2%) | −110.9 | −108.6 | 0.23 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 255 / 9452 (2.7%) | 8005 / 94520 (8.5%) | −110.6 | −108.3 | 0.32 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 231 / 9452 (2.4%) | 7612 / 94520 (8.1%) | −110.6 | −108.3 | 0.30 |
| SMARCA4 SRX5212366 | Mel270 Others | 235 / 9452 (2.5%) | 7675 / 94520 (8.1%) | −110.5 | −108.2 | 0.31 |
| Epitope tags SRX7276677 | 293 Kidney | 1573 / 9452 (16.6%) | 8443 / 94520 (8.9%) | −110.5 | −108.2 | 1.86 |
| CTCF SRX10975999 | NALM-6 Blood | 1843 / 9452 (19.5%) | 10529 / 94520 (11.1%) | −110.2 | −107.9 | 1.75 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 153 / 9452 (1.6%) | 6243 / 94520 (6.6%) | −110.0 | −107.8 | 0.25 |
| FOXL2 SRX6957477 | KGN Gonad | 169 / 9452 (1.8%) | 6520 / 94520 (6.9%) | −109.7 | −107.5 | 0.26 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 168 / 9452 (1.8%) | 6502 / 94520 (6.9%) | −109.6 | −107.4 | 0.26 |
| FOXA1 SRX11222437 | MCF-7 Breast | 113 / 9452 (1.2%) | 5464 / 94520 (5.8%) | −109.1 | −106.9 | 0.21 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 154 / 9452 (1.6%) | 6234 / 94520 (6.6%) | −109.1 | −106.8 | 0.25 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 469 / 9452 (5.0%) | 11206 / 94520 (11.9%) | −109.0 | −106.7 | 0.42 |
| FOXA1 SRX11222442 | MCF-7 Breast | 101 / 9452 (1.1%) | 5220 / 94520 (5.5%) | −108.9 | −106.6 | 0.19 |
| MEAF6 DRX234811 | 293 Kidney | 976 / 9452 (10.3%) | 4230 / 94520 (4.5%) | −108.8 | −106.6 | 2.31 |
| FOSL2 SRX190296 | SK-N-SH Neural | 236 / 9452 (2.5%) | 7629 / 94520 (8.1%) | −108.6 | −106.4 | 0.31 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 210 / 9452 (2.2%) | 7191 / 94520 (7.6%) | −108.5 | −106.3 | 0.29 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 930 / 9452 (9.8%) | 3946 / 94520 (4.2%) | −107.8 | −105.6 | 2.36 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 653 / 9452 (6.9%) | 2234 / 94520 (2.4%) | −107.8 | −105.5 | 2.92 |
| JUN SRX6582172 | Fibroblasts Others | 230 / 9452 (2.4%) | 7502 / 94520 (7.9%) | −107.7 | −105.5 | 0.31 |
| NKX2-1 SRX2164786 | A549 Lung | 308 / 9452 (3.3%) | 8751 / 94520 (9.3%) | −107.6 | −105.3 | 0.35 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 251 / 9452 (2.7%) | 7838 / 94520 (8.3%) | −107.5 | −105.3 | 0.32 |
| NUP98 SRX20440536 | Keratinocytes Epidermis | 321 / 9452 (3.4%) | 575 / 94520 (0.6%) | −107.2 | −104.9 | 5.58 |
| SMARCA4 SRX5212357 | Mel270 Others | 261 / 9452 (2.8%) | 7986 / 94520 (8.4%) | −107.0 | −104.7 | 0.33 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 365 / 9452 (3.9%) | 9590 / 94520 (10.1%) | −106.7 | −104.5 | 0.38 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 214 / 9452 (2.3%) | 7201 / 94520 (7.6%) | −106.6 | −104.4 | 0.30 |
| GRHL3 SRX2582161 | NHEK Epidermis | 571 / 9452 (6.0%) | 1787 / 94520 (1.9%) | −106.6 | −104.4 | 3.20 |
| FOXA1 SRX3931043 | MCF-7 Breast | 176 / 9452 (1.9%) | 6544 / 94520 (6.9%) | −106.5 | −104.3 | 0.27 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 156 / 9452 (1.7%) | 6191 / 94520 (6.5%) | −106.5 | −104.3 | 0.25 |
| TLE3 SRX4815191 | MCF-7 Breast | 170 / 9452 (1.8%) | 6441 / 94520 (6.8%) | −106.5 | −104.3 | 0.26 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 319 / 9452 (3.4%) | 8879 / 94520 (9.4%) | −106.4 | −104.2 | 0.36 |
| NFYB SRX16608147 | HeLa Uterus | 183 / 9452 (1.9%) | 128 / 94520 (0.1%) | −106.3 | −104.1 | 14.30 |
| CEBPB SRX150632 | HeLa Uterus | 430 / 9452 (4.5%) | 10540 / 94520 (11.2%) | −106.3 | −104.1 | 0.41 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 428 / 9452 (4.5%) | 10503 / 94520 (11.1%) | −106.1 | −103.9 | 0.41 |
| FOXA1 SRX371480 | MCF-7 Breast | 112 / 9452 (1.2%) | 5355 / 94520 (5.7%) | −106.0 | −103.8 | 0.21 |
| FOXA1 SRX1787653 | MCF-7 Breast | 138 / 9452 (1.5%) | 5839 / 94520 (6.2%) | −105.7 | −103.5 | 0.24 |
| ESR1 SRX371469 | MCF-7 Breast | 192 / 9452 (2.0%) | 6793 / 94520 (7.2%) | −105.6 | −103.4 | 0.28 |
| MEAF6 DRX300417 | 293 Kidney | 888 / 9452 (9.4%) | 3718 / 94520 (3.9%) | −105.4 | −103.2 | 2.39 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 325 / 9452 (3.4%) | 8933 / 94520 (9.5%) | −105.2 | −103.0 | 0.36 |
| PRRX1 SRX15235713 | Hs 578T Breast | 216 / 9452 (2.3%) | 7184 / 94520 (7.6%) | −105.1 | −103.0 | 0.30 |
| ESR1 SRX20282961 | MCF-7 Breast | 238 / 9452 (2.5%) | 7549 / 94520 (8.0%) | −105.1 | −102.9 | 0.32 |
| NR3C1 SRX2609664 | HASM2 Lung | 259 / 9452 (2.7%) | 7863 / 94520 (8.3%) | −104.3 | −102.1 | 0.33 |
| ESR1 SRX7624156 | MCF-7 Breast | 308 / 9452 (3.3%) | 8636 / 94520 (9.1%) | −104.3 | −102.1 | 0.36 |
| JUNB SRX8488088 | SUM 229PE Breast | 370 / 9452 (3.9%) | 9577 / 94520 (10.1%) | −104.2 | −102.0 | 0.39 |
| FOS SRX150476 | MCF 10A Breast | 334 / 9452 (3.5%) | 9033 / 94520 (9.6%) | −104.2 | −102.0 | 0.37 |
| CHD6 SRX17709201 | C4-2 Prostate | 903 / 9452 (9.6%) | 3839 / 94520 (4.1%) | −104.1 | −101.9 | 2.35 |
| JUN SRX6582171 | GM07492 Others | 367 / 9452 (3.9%) | 9522 / 94520 (10.1%) | −103.9 | −101.7 | 0.39 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 262 / 9452 (2.8%) | 7883 / 94520 (8.3%) | −103.5 | −101.3 | 0.33 |
| MethylCap SRX026646 | Acute myeloid leukemia Blood | 421 / 9452 (4.5%) | 1047 / 94520 (1.1%) | −103.4 | −101.2 | 4.02 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 194 / 9452 (2.1%) | 6750 / 94520 (7.1%) | −103.2 | −101.0 | 0.29 |
| PBX3 SRX190343 | SK-N-SH Neural | 397 / 9452 (4.2%) | 9940 / 94520 (10.5%) | −103.1 | −100.9 | 0.40 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 828 / 9452 (8.8%) | 3375 / 94520 (3.6%) | −103.0 | −100.9 | 2.45 |
| SMARCA4 SRX5212371 | Mel270 Others | 262 / 9452 (2.8%) | 7866 / 94520 (8.3%) | −103.0 | −100.9 | 0.33 |
| RAC1 SRX10365541 | MCF-7 Breast | 82 / 9452 (0.9%) | 4663 / 94520 (4.9%) | −102.9 | −100.7 | 0.18 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 247 / 9452 (2.6%) | 7612 / 94520 (8.1%) | −102.6 | −100.4 | 0.32 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 368 / 9452 (3.9%) | 9489 / 94520 (10.0%) | −102.6 | −100.4 | 0.39 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1319 / 9452 (14.0%) | 6769 / 94520 (7.2%) | −102.6 | −100.4 | 1.95 |
| FOXA1 SRX219284 | LNCAP Prostate | 240 / 9452 (2.5%) | 7495 / 94520 (7.9%) | −102.5 | −100.4 | 0.32 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 238 / 9452 (2.5%) | 7459 / 94520 (7.9%) | −102.4 | −100.3 | 0.32 |
| Epitope tags SRX10549777 | K-562 Blood | 1409 / 9452 (14.9%) | 7439 / 94520 (7.9%) | −102.3 | −100.2 | 1.89 |
| JUND SRX190357 | SK-N-SH Neural | 231 / 9452 (2.4%) | 7334 / 94520 (7.8%) | −102.1 | −100.0 | 0.31 |
| FOS SRX070879 | HUVEC Cardiovascular | 189 / 9452 (2.0%) | 6630 / 94520 (7.0%) | −102.0 | −99.9 | 0.29 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 168 / 9452 (1.8%) | 6262 / 94520 (6.6%) | −101.8 | −99.7 | 0.27 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 124 / 9452 (1.3%) | 5461 / 94520 (5.8%) | −101.8 | −99.6 | 0.23 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 161 / 9452 (1.7%) | 6122 / 94520 (6.5%) | −101.5 | −99.3 | 0.26 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 280 / 9452 (3.0%) | 8102 / 94520 (8.6%) | −101.4 | −99.3 | 0.35 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 323 / 9452 (3.4%) | 8766 / 94520 (9.3%) | −101.4 | −99.3 | 0.37 |
| FOXA1 SRX3923517 | MCF-7 Breast | 120 / 9452 (1.3%) | 5373 / 94520 (5.7%) | −101.3 | −99.2 | 0.22 |
| YAP1 SRX1038945 | IMR-90 Lung | 126 / 9452 (1.3%) | 5484 / 94520 (5.8%) | −101.3 | −99.2 | 0.23 |
| JUN SRX2355072 | HAEC Cardiovascular | 244 / 9452 (2.6%) | 7513 / 94520 (7.9%) | −101.1 | −99.0 | 0.32 |
| ESR1 SRX371476 | MCF-7 Breast | 133 / 9452 (1.4%) | 5605 / 94520 (5.9%) | −101.1 | −99.0 | 0.24 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 183 / 9452 (1.9%) | 6496 / 94520 (6.9%) | −101.1 | −99.0 | 0.28 |
| FOXA1 SRX1787652 | MCF-7 Breast | 99 / 9452 (1.0%) | 4952 / 94520 (5.2%) | −100.9 | −98.8 | 0.20 |
| ESR1 SRX10365536 | MCF-7 Breast | 87 / 9452 (0.9%) | 4699 / 94520 (5.0%) | −100.4 | −98.3 | 0.19 |
| JUN SRX883584 | MDA-MB-231 Breast | 303 / 9452 (3.2%) | 8416 / 94520 (8.9%) | −100.1 | −98.0 | 0.36 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 201 / 9452 (2.1%) | 6771 / 94520 (7.2%) | −100.0 | −97.9 | 0.30 |
| FOXA1 SRX100506 | Hep G2 Liver | 249 / 9452 (2.6%) | 7561 / 94520 (8.0%) | −100.0 | −97.9 | 0.33 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 169 / 9452 (1.8%) | 6218 / 94520 (6.6%) | −100.0 | −97.9 | 0.27 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 141 / 9452 (1.5%) | 5717 / 94520 (6.0%) | −99.9 | −97.8 | 0.25 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 572 / 9452 (6.1%) | 12303 / 94520 (13.0%) | −99.9 | −97.8 | 0.46 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 777 / 9452 (8.2%) | 3108 / 94520 (3.3%) | −99.7 | −97.6 | 2.50 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 149 / 9452 (1.6%) | 5850 / 94520 (6.2%) | −99.6 | −97.5 | 0.25 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 336 / 9452 (3.6%) | 8897 / 94520 (9.4%) | −99.6 | −97.4 | 0.38 |
| FOXA2 SRX3644342 | BJ Epidermis | 279 / 9452 (3.0%) | 8015 / 94520 (8.5%) | −99.4 | −97.3 | 0.35 |
| FOXA1 SRX100454 | T-47D Breast | 248 / 9452 (2.6%) | 7510 / 94520 (7.9%) | −99.1 | −97.0 | 0.33 |
| FOXA2 SRX100448 | Hep G2 Liver | 205 / 9452 (2.2%) | 6805 / 94520 (7.2%) | −99.1 | −97.0 | 0.30 |
| FOXA1 SRX3931054 | MCF-7 Breast | 172 / 9452 (1.8%) | 6241 / 94520 (6.6%) | −99.0 | −96.9 | 0.28 |
| LARP7 SRX2198835 | HeLa Uterus | 1212 / 9452 (12.8%) | 6081 / 94520 (6.4%) | −99.0 | −96.9 | 1.99 |
| FOXA1 SRX1787655 | MCF-7 Breast | 78 / 9452 (0.8%) | 4472 / 94520 (4.7%) | −98.9 | −96.8 | 0.17 |
| FOXA1 SRX3923518 | MCF-7 Breast | 118 / 9452 (1.2%) | 5261 / 94520 (5.6%) | −98.9 | −96.8 | 0.22 |
| JUNB SRX10119386 | MCF 10A Breast | 165 / 9452 (1.7%) | 6108 / 94520 (6.5%) | −98.8 | −96.7 | 0.27 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 125 / 9452 (1.3%) | 5383 / 94520 (5.7%) | −98.6 | −96.5 | 0.23 |
| FOXA1 SRX3923516 | MCF-7 Breast | 126 / 9452 (1.3%) | 5396 / 94520 (5.7%) | −98.4 | −96.3 | 0.23 |
| FOXA1 SRX11222438 | MCF-7 Breast | 86 / 9452 (0.9%) | 4611 / 94520 (4.9%) | −98.0 | −95.9 | 0.19 |
| ESR1 SRX176860 | MCF-7 Breast | 330 / 9452 (3.5%) | 8750 / 94520 (9.3%) | −98.0 | −95.9 | 0.38 |
| FOXA1 SRX3931055 | MCF-7 Breast | 156 / 9452 (1.7%) | 5930 / 94520 (6.3%) | −98.0 | −95.9 | 0.26 |
| TLE3 SRX4815192 | MCF-7 Breast | 167 / 9452 (1.8%) | 6119 / 94520 (6.5%) | −97.9 | −95.8 | 0.27 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 134 / 9452 (1.4%) | 5526 / 94520 (5.8%) | −97.8 | −95.7 | 0.24 |
| FOXA1 SRX028634 | MCF-7 Breast | 77 / 9452 (0.8%) | 4419 / 94520 (4.7%) | −97.8 | −95.7 | 0.17 |
| FOXA2 SRX3230382 | Hep G2 Liver | 259 / 9452 (2.7%) | 7640 / 94520 (8.1%) | −97.8 | −95.7 | 0.34 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 284 / 9452 (3.0%) | 8036 / 94520 (8.5%) | −97.7 | −95.7 | 0.35 |
| FOXA1 SRX5323843 | MCF-7 Breast | 85 / 9452 (0.9%) | 4579 / 94520 (4.8%) | −97.7 | −95.6 | 0.19 |
| MYOCD SRX5598318 | A549 Lung | 997 / 9452 (10.5%) | 4605 / 94520 (4.9%) | −97.5 | −95.4 | 2.17 |
| FOXA1 SRX1161174 | MCF-7 Breast | 196 / 9452 (2.1%) | 6601 / 94520 (7.0%) | −97.5 | −95.4 | 0.30 |
| FOS SRX4192879 | MCF 10A Breast | 228 / 9452 (2.4%) | 7130 / 94520 (7.5%) | −97.3 | −95.3 | 0.32 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 989 / 9452 (10.5%) | 4563 / 94520 (4.8%) | −96.9 | −94.8 | 2.17 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 249 / 9452 (2.6%) | 7441 / 94520 (7.9%) | −96.6 | −94.5 | 0.33 |
| TET2 SRX1427029 | 293 Kidney | 755 / 9452 (8.0%) | 3029 / 94520 (3.2%) | −96.4 | −94.3 | 2.49 |
| CBFB SRX265218 | ME-1 Blood | 864 / 9452 (9.1%) | 3733 / 94520 (3.9%) | −96.3 | −94.3 | 2.31 |
| FOXA1 SRX5203303 | MCF-7 Breast | 46 / 9452 (0.5%) | 3693 / 94520 (3.9%) | −96.2 | −94.1 | 0.12 |
| ESR1 SRX371479 | MCF-7 Breast | 184 / 9452 (1.9%) | 6351 / 94520 (6.7%) | −95.9 | −93.9 | 0.29 |
| FOXA1 SRX6878603 | LNCAP Prostate | 206 / 9452 (2.2%) | 6716 / 94520 (7.1%) | −95.9 | −93.9 | 0.31 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 251 / 9452 (2.7%) | 7448 / 94520 (7.9%) | −95.9 | −93.8 | 0.34 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 167 / 9452 (1.8%) | 6049 / 94520 (6.4%) | −95.7 | −93.7 | 0.28 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 344 / 9452 (3.6%) | 8878 / 94520 (9.4%) | −95.7 | −93.6 | 0.39 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 209 / 9452 (2.2%) | 6751 / 94520 (7.1%) | −95.4 | −93.4 | 0.31 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 175 / 9452 (1.9%) | 6179 / 94520 (6.5%) | −95.4 | −93.3 | 0.28 |
| EP300 SRX150579 | HeLa Uterus | 118 / 9452 (1.2%) | 5157 / 94520 (5.5%) | −95.4 | −93.3 | 0.23 |
| RELA SRX7055007 | HAEC Cardiovascular | 359 / 9452 (3.8%) | 9089 / 94520 (9.6%) | −95.3 | −93.3 | 0.39 |
| EP300 SRX100540 | SK-N-SH Neural | 287 / 9452 (3.0%) | 7996 / 94520 (8.5%) | −95.3 | −93.3 | 0.36 |
| NR3C1 SRX2609659 | HASM2 Lung | 232 / 9452 (2.5%) | 7100 / 94520 (7.5%) | −94.6 | −92.6 | 0.33 |
| FOXA1 SRX9604647 | LNCAP Prostate | 292 / 9452 (3.1%) | 8046 / 94520 (8.5%) | −94.5 | −92.5 | 0.36 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 725 / 9452 (7.7%) | 2871 / 94520 (3.0%) | −94.4 | −92.4 | 2.53 |
| CEBPA SRX4705113 | MOLM-13 Blood | 465 / 9452 (4.9%) | 10581 / 94520 (11.2%) | −94.1 | −92.0 | 0.44 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 196 / 9452 (2.1%) | 6490 / 94520 (6.9%) | −94.0 | −92.0 | 0.30 |
| AR SRX1067067 | LHSAR Prostate | 340 / 9452 (3.6%) | 8753 / 94520 (9.3%) | −93.9 | −91.9 | 0.39 |
| NR3C1 SRX2609662 | HASM2 Lung | 235 / 9452 (2.5%) | 7127 / 94520 (7.5%) | −93.9 | −91.9 | 0.33 |
| JUNB SRX4192882 | MCF 10A Breast | 153 / 9452 (1.6%) | 5740 / 94520 (6.1%) | −93.7 | −91.7 | 0.27 |
| GATA3 SRX5457550 | MCF-7 Breast | 220 / 9452 (2.3%) | 6869 / 94520 (7.3%) | −93.5 | −91.5 | 0.32 |
| FOSL2 SRX190204 | A549 Lung | 188 / 9452 (2.0%) | 6338 / 94520 (6.7%) | −93.5 | −91.5 | 0.30 |
| ESR1 SRX10365532 | MCF-7 Breast | 97 / 9452 (1.0%) | 4700 / 94520 (5.0%) | −93.5 | −91.4 | 0.21 |
| FOXA1 SRX6878604 | LNCAP Prostate | 144 / 9452 (1.5%) | 5575 / 94520 (5.9%) | −93.5 | −91.4 | 0.26 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 185 / 9452 (2.0%) | 6279 / 94520 (6.6%) | −93.3 | −91.3 | 0.29 |
| FOXA1 SRX3923519 | MCF-7 Breast | 110 / 9452 (1.2%) | 4944 / 94520 (5.2%) | −93.3 | −91.3 | 0.22 |
| FOXA1 SRX1787651 | MCF-7 Breast | 100 / 9452 (1.1%) | 4754 / 94520 (5.0%) | −93.3 | −91.3 | 0.21 |
| FOXL2 SRX5342375 | SVOG-3e Gonad | 142 / 9452 (1.5%) | 5531 / 94520 (5.9%) | −93.3 | −91.3 | 0.26 |
| FOXA1 SRX219285 | LNCAP Prostate | 171 / 9452 (1.8%) | 6040 / 94520 (6.4%) | −93.2 | −91.2 | 0.28 |
| FOXA1 SRX1447317 | MCF-7 Breast | 115 / 9452 (1.2%) | 5034 / 94520 (5.3%) | −93.2 | −91.2 | 0.23 |
| RAC1 SRX10365543 | MCF-7 Breast | 96 / 9452 (1.0%) | 4662 / 94520 (4.9%) | −93.0 | −90.9 | 0.21 |
| FOS SRX150664 | HUVEC Cardiovascular | 261 / 9452 (2.8%) | 7508 / 94520 (7.9%) | −93.0 | −90.9 | 0.35 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 159 / 9452 (1.7%) | 5820 / 94520 (6.2%) | −92.9 | −90.8 | 0.27 |
| ESR1 SRX20282939 | MCF-7 Breast | 234 / 9452 (2.5%) | 7073 / 94520 (7.5%) | −92.8 | −90.8 | 0.33 |
| FOXA1 SRX1885181 | LNCAP Prostate | 166 / 9452 (1.8%) | 5931 / 94520 (6.3%) | −92.6 | −90.5 | 0.28 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 262 / 9452 (2.8%) | 7509 / 94520 (7.9%) | −92.6 | −90.5 | 0.35 |
| GATA3 SRX6712581 | MCF-7 Breast | 155 / 9452 (1.6%) | 5737 / 94520 (6.1%) | −92.5 | −90.4 | 0.27 |
| FOXA1 SRX028635 | MCF-7 Breast | 89 / 9452 (0.9%) | 4505 / 94520 (4.8%) | −92.3 | −90.3 | 0.20 |
| ESR1 SRX371470 | ZR-75-1 Breast | 186 / 9452 (2.0%) | 6250 / 94520 (6.6%) | −91.9 | −89.9 | 0.30 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 318 / 9452 (3.4%) | 8343 / 94520 (8.8%) | −91.8 | −89.7 | 0.38 |
| AR SRX1067068 | LHSAR Prostate | 230 / 9452 (2.4%) | 6972 / 94520 (7.4%) | −91.7 | −89.7 | 0.33 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1041 / 9452 (11.0%) | 5045 / 94520 (5.3%) | −91.5 | −89.5 | 2.06 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 181 / 9452 (1.9%) | 6154 / 94520 (6.5%) | −91.4 | −89.4 | 0.29 |
| FOXA1 SRX5203294 | MCF-7 Breast | 40 / 9452 (0.4%) | 3410 / 94520 (3.6%) | −90.9 | −88.9 | 0.12 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 901 / 9452 (9.5%) | 4091 / 94520 (4.3%) | −90.9 | −88.9 | 2.20 |
| AR SRX1067066 | LHSAR Prostate | 426 / 9452 (4.5%) | 9894 / 94520 (10.5%) | −90.8 | −88.8 | 0.43 |
| KAT7 DRX234808 | 293 Kidney | 447 / 9452 (4.7%) | 1310 / 94520 (1.4%) | −90.6 | −88.6 | 3.41 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 378 / 9452 (4.0%) | 9192 / 94520 (9.7%) | −90.6 | −88.6 | 0.41 |
| FOXA1 SRX2017929 | LNCAP Prostate | 264 / 9452 (2.8%) | 7470 / 94520 (7.9%) | −90.5 | −88.5 | 0.35 |
| Epitope tags DRX443510 | 293 Kidney | 805 / 9452 (8.5%) | 3465 / 94520 (3.7%) | −90.2 | −88.2 | 2.32 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 181 / 9452 (1.9%) | 6111 / 94520 (6.5%) | −90.2 | −88.2 | 0.30 |
| JUN SRX6582163 | BJ-5ta Epidermis | 260 / 9452 (2.8%) | 7392 / 94520 (7.8%) | −90.1 | −88.1 | 0.35 |
| ESR1 SRX194572 | MCF-7 Breast | 126 / 9452 (1.3%) | 5146 / 94520 (5.4%) | −90.1 | −88.1 | 0.24 |
| FOXL2 SRX6957481 | KGN Gonad | 113 / 9452 (1.2%) | 4901 / 94520 (5.2%) | −90.0 | −88.0 | 0.23 |
| EP300 SRX2194266 | SUM 159PT Breast | 357 / 9452 (3.8%) | 8857 / 94520 (9.4%) | −89.8 | −87.9 | 0.40 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 140 / 9452 (1.5%) | 5389 / 94520 (5.7%) | −89.8 | −87.9 | 0.26 |
| RELA SRX7054657 | HAEC Cardiovascular | 227 / 9452 (2.4%) | 6859 / 94520 (7.3%) | −89.8 | −87.9 | 0.33 |
| NR3C1 SRX2609661 | HASM2 Lung | 228 / 9452 (2.4%) | 6874 / 94520 (7.3%) | −89.8 | −87.8 | 0.33 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 236 / 9452 (2.5%) | 6998 / 94520 (7.4%) | −89.8 | −87.8 | 0.34 |
| ESR1 SRX1531791 | MCF-7 Breast | 203 / 9452 (2.1%) | 6466 / 94520 (6.8%) | −89.8 | −87.8 | 0.31 |
| ESR1 SRX20282960 | MCF-7 Breast | 245 / 9452 (2.6%) | 7144 / 94520 (7.6%) | −89.7 | −87.7 | 0.34 |
| Epitope tags SRX2255895 | 293 Kidney | 561 / 9452 (5.9%) | 1955 / 94520 (2.1%) | −89.7 | −87.7 | 2.87 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 275 / 9452 (2.9%) | 7609 / 94520 (8.1%) | −89.6 | −87.6 | 0.36 |
| ESR1 SRX371471 | ZR-75-1 Breast | 231 / 9452 (2.4%) | 6911 / 94520 (7.3%) | −89.5 | −87.6 | 0.33 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 236 / 9452 (2.5%) | 6990 / 94520 (7.4%) | −89.5 | −87.5 | 0.34 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 868 / 9452 (9.2%) | 3896 / 94520 (4.1%) | −89.5 | −87.5 | 2.23 |
| ARID5B SRX3230377 | Hep G2 Liver | 517 / 9452 (5.5%) | 11116 / 94520 (11.8%) | −89.3 | −87.4 | 0.47 |
| TET2 SRX2513053 | Jurkat Blood | 1189 / 9452 (12.6%) | 6164 / 94520 (6.5%) | −89.3 | −87.4 | 1.93 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 133 / 9452 (1.4%) | 5245 / 94520 (5.5%) | −89.2 | −87.2 | 0.25 |
| JUND SRX150408 | HeLa Uterus | 177 / 9452 (1.9%) | 6009 / 94520 (6.4%) | −89.1 | −87.2 | 0.29 |
| NR3C1 SRX2609665 | HASM2 Lung | 224 / 9452 (2.4%) | 6783 / 94520 (7.2%) | −89.0 | −87.1 | 0.33 |
| ESR1 SRX371467 | MCF-7 Breast | 222 / 9452 (2.3%) | 6741 / 94520 (7.1%) | −88.8 | −86.8 | 0.33 |
| CDK9 SRX20230567 | Ishikawa Uterus | 987 / 9452 (10.4%) | 4732 / 94520 (5.0%) | −88.6 | −86.6 | 2.09 |
| FOXA1 SRX3931033 | MCF-7 Breast | 122 / 9452 (1.3%) | 5021 / 94520 (5.3%) | −88.4 | −86.5 | 0.24 |
| FOXA1 SRX100477 | Hep G2 Liver | 231 / 9452 (2.4%) | 6876 / 94520 (7.3%) | −88.4 | −86.5 | 0.34 |
| JUN SRX2355073 | HAEC Cardiovascular | 256 / 9452 (2.7%) | 7258 / 94520 (7.7%) | −88.1 | −86.1 | 0.35 |
| JUN SRX150358 | HUVEC Cardiovascular | 124 / 9452 (1.3%) | 5045 / 94520 (5.3%) | −88.0 | −86.0 | 0.25 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 170 / 9452 (1.8%) | 5852 / 94520 (6.2%) | −87.9 | −86.0 | 0.29 |
| ESR1 SRX176861 | MCF-7 Breast | 351 / 9452 (3.7%) | 8695 / 94520 (9.2%) | −87.9 | −86.0 | 0.40 |
| ESR1 SRX4367193 | MCF-7 Breast | 672 / 9452 (7.1%) | 13144 / 94520 (13.9%) | −87.9 | −86.0 | 0.51 |
| RBM22 SRX4708083 | K-562 Blood | 538 / 9452 (5.7%) | 1845 / 94520 (2.0%) | −87.9 | −86.0 | 2.92 |
| TEAD1 SRX3401272 | MCF-7 Breast | 147 / 9452 (1.6%) | 5450 / 94520 (5.8%) | −87.9 | −85.9 | 0.27 |
| FOXA1 SRX2017928 | LNCAP Prostate | 234 / 9452 (2.5%) | 6903 / 94520 (7.3%) | −87.9 | −85.9 | 0.34 |
| ESR1 SRX194569 | MCF-7 Breast | 222 / 9452 (2.3%) | 6708 / 94520 (7.1%) | −87.8 | −85.9 | 0.33 |
| JUN SRX6582164 | BJ-5ta Epidermis | 266 / 9452 (2.8%) | 7394 / 94520 (7.8%) | −87.6 | −85.6 | 0.36 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 169 / 9452 (1.8%) | 5821 / 94520 (6.2%) | −87.5 | −85.6 | 0.29 |
| CEBPB SRX150598 | IMR-90 Lung | 427 / 9452 (4.5%) | 9780 / 94520 (10.3%) | −87.5 | −85.5 | 0.44 |
| ESR1 SRX20282954 | MCF-7 Breast | 236 / 9452 (2.5%) | 6918 / 94520 (7.3%) | −87.4 | −85.5 | 0.34 |
| EP300 SRX2194265 | SUM 159PT Breast | 332 / 9452 (3.5%) | 8395 / 94520 (8.9%) | −87.4 | −85.5 | 0.40 |
| RELA SRX7054617 | HAEC Cardiovascular | 245 / 9452 (2.6%) | 7061 / 94520 (7.5%) | −87.4 | −85.5 | 0.35 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 278 / 9452 (2.9%) | 7574 / 94520 (8.0%) | −87.4 | −85.4 | 0.37 |
| NABP2 SRX9523535 | HT-1080 Bone | 770 / 9452 (8.1%) | 3290 / 94520 (3.5%) | −87.3 | −85.4 | 2.34 |
| FOXA1 SRX5323845 | MCF-7 Breast | 63 / 9452 (0.7%) | 3830 / 94520 (4.1%) | −87.3 | −85.3 | 0.16 |
| DDX21 SRX8257415 | A-375 Epidermis | 541 / 9452 (5.7%) | 1875 / 94520 (2.0%) | −87.2 | −85.2 | 2.89 |
| FOXA1 SRX1885184 | LNCAP Prostate | 182 / 9452 (1.9%) | 6028 / 94520 (6.4%) | −87.1 | −85.2 | 0.30 |
| SUZ12 SRX10184494 | K-562 Blood | 1383 / 9452 (14.6%) | 7677 / 94520 (8.1%) | −87.1 | −85.2 | 1.80 |
| KLF4 SRX12144701 | T/C28a2 Bone | 1518 / 9452 (16.1%) | 8719 / 94520 (9.2%) | −87.0 | −85.0 | 1.74 |
| FOXA1 SRX2642368 | VCaP Prostate | 243 / 9452 (2.6%) | 7013 / 94520 (7.4%) | −86.9 | −84.9 | 0.35 |
| FOXA1 SRX190181 | A549 Lung | 144 / 9452 (1.5%) | 5366 / 94520 (5.7%) | −86.8 | −84.9 | 0.27 |
| FOXA1 SRX1885182 | LNCAP Prostate | 163 / 9452 (1.7%) | 5695 / 94520 (6.0%) | −86.7 | −84.8 | 0.29 |
| FOXA1 SRX497612 | VCaP Prostate | 182 / 9452 (1.9%) | 6008 / 94520 (6.4%) | −86.6 | −84.6 | 0.30 |
| AR SRX1067069 | LHSAR Prostate | 250 / 9452 (2.6%) | 7105 / 94520 (7.5%) | −86.5 | −84.5 | 0.35 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 261 / 9452 (2.8%) | 7276 / 94520 (7.7%) | −86.3 | −84.4 | 0.36 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 193 / 9452 (2.0%) | 6176 / 94520 (6.5%) | −86.0 | −84.1 | 0.31 |
| KMT2A SRX2281249 | SEM Blood | 1076 / 9452 (11.4%) | 5434 / 94520 (5.7%) | −85.8 | −83.9 | 1.98 |
| SMARCA4 SRX5982340 | A549 Lung | 70 / 9452 (0.7%) | 3927 / 94520 (4.2%) | −85.6 | −83.7 | 0.18 |
| JUNB SRX8488089 | SUM 229PE Breast | 213 / 9452 (2.3%) | 6478 / 94520 (6.9%) | −85.3 | −83.4 | 0.33 |
| FOXA1 SRX5323846 | MCF-7 Breast | 68 / 9452 (0.7%) | 3877 / 94520 (4.1%) | −85.3 | −83.3 | 0.18 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 58 / 9452 (0.6%) | 3663 / 94520 (3.9%) | −85.2 | −83.3 | 0.16 |
| FOS SRX3322636 | MCF-7 Breast | 137 / 9452 (1.4%) | 5188 / 94520 (5.5%) | −85.2 | −83.2 | 0.26 |
| CDK9 SRX20230570 | Ishikawa Uterus | 951 / 9452 (10.1%) | 4562 / 94520 (4.8%) | −85.1 | −83.1 | 2.08 |
| GATA3 SRX11149845 | MDA-MB-453 Breast | 213 / 9452 (2.3%) | 6468 / 94520 (6.8%) | −85.0 | −83.1 | 0.33 |
| FOXA1 SRX15430999 | T-47D Breast | 231 / 9452 (2.4%) | 6754 / 94520 (7.1%) | −85.0 | −83.1 | 0.34 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 327 / 9452 (3.5%) | 8233 / 94520 (8.7%) | −85.0 | −83.1 | 0.40 |
| FOXA1 SRX3923515 | MCF-7 Breast | 110 / 9452 (1.2%) | 4692 / 94520 (5.0%) | −85.0 | −83.0 | 0.23 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 166 / 9452 (1.8%) | 5684 / 94520 (6.0%) | −84.9 | −83.0 | 0.29 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 844 / 9452 (8.9%) | 3833 / 94520 (4.1%) | −84.9 | −83.0 | 2.20 |
| FOXA1 SRX5203307 | MCF-7 Breast | 49 / 9452 (0.5%) | 3457 / 94520 (3.7%) | −84.9 | −83.0 | 0.14 |
| JUNB SRX10119384 | MCF 10A Breast | 125 / 9452 (1.3%) | 4964 / 94520 (5.3%) | −84.8 | −82.9 | 0.25 |
| MAU2 SRX15710550 | Fibroblasts Others | 354 / 9452 (3.7%) | 8624 / 94520 (9.1%) | −84.8 | −82.9 | 0.41 |
| VGLL1 SRX24602130 | BT-20 Breast | 223 / 9452 (2.4%) | 6621 / 94520 (7.0%) | −84.8 | −82.9 | 0.34 |
| ARID1A SRX5089376 | MCF-7 Breast | 181 / 9452 (1.9%) | 5931 / 94520 (6.3%) | −84.8 | −82.9 | 0.31 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 160 / 9452 (1.7%) | 5575 / 94520 (5.9%) | −84.7 | −82.8 | 0.29 |
| FOXA1 SRX1885185 | LNCAP Prostate | 149 / 9452 (1.6%) | 5388 / 94520 (5.7%) | −84.7 | −82.8 | 0.28 |
| ETS1 SRX3033231 | HEYA8 Gonad | 185 / 9452 (2.0%) | 210 / 94520 (0.2%) | −84.7 | −82.8 | 8.81 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 297 / 9452 (3.1%) | 7765 / 94520 (8.2%) | −84.7 | −82.8 | 0.38 |
| FOXA1 SRX667985 | VCaP Prostate | 149 / 9452 (1.6%) | 5382 / 94520 (5.7%) | −84.6 | −82.7 | 0.28 |
| AR SRX9468652 | LNCAP Prostate | 176 / 9452 (1.9%) | 5840 / 94520 (6.2%) | −84.5 | −82.6 | 0.30 |
| CEBPA SRX2630241 | Hep G2 Liver | 255 / 9452 (2.7%) | 7109 / 94520 (7.5%) | −84.3 | −82.4 | 0.36 |
| ARID1A SRX5089379 | MCF-7 Breast | 203 / 9452 (2.1%) | 6284 / 94520 (6.6%) | −84.3 | −82.4 | 0.32 |
| FOXA1 SRX1161203 | T-47D Breast | 149 / 9452 (1.6%) | 5370 / 94520 (5.7%) | −84.3 | −82.4 | 0.28 |
| ESR1 SRX371468 | MCF-7 Breast | 137 / 9452 (1.4%) | 5159 / 94520 (5.5%) | −84.3 | −82.4 | 0.27 |
| DPF2 SRX3927297 | MOLM-13 Blood | 252 / 9452 (2.7%) | 7060 / 94520 (7.5%) | −84.2 | −82.3 | 0.36 |
| YAP1 SRX10119364 | MCF 10A Breast | 177 / 9452 (1.9%) | 5848 / 94520 (6.2%) | −84.2 | −82.3 | 0.30 |
| FOXA1 SRX497613 | VCaP Prostate | 135 / 9452 (1.4%) | 5119 / 94520 (5.4%) | −84.1 | −82.2 | 0.26 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 310 / 9452 (3.3%) | 7940 / 94520 (8.4%) | −84.1 | −82.2 | 0.39 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 94 / 9452 (1.0%) | 4364 / 94520 (4.6%) | −84.1 | −82.2 | 0.22 |
| AR SRX9469988 | LAPC-4 Prostate | 278 / 9452 (2.9%) | 7456 / 94520 (7.9%) | −84.1 | −82.2 | 0.37 |
| FOXA1 SRX3931056 | MCF-7 Breast | 119 / 9452 (1.3%) | 4829 / 94520 (5.1%) | −84.0 | −82.1 | 0.25 |
| SMARCA4 SRX5982364 | A549 Lung | 57 / 9452 (0.6%) | 3600 / 94520 (3.8%) | −83.8 | −81.9 | 0.16 |
| ESR1 SRX371477 | MCF-7 Breast | 100 / 9452 (1.1%) | 4464 / 94520 (4.7%) | −83.7 | −81.8 | 0.22 |
| AR SRX9468662 | LNCAP Prostate | 204 / 9452 (2.2%) | 6273 / 94520 (6.6%) | −83.6 | −81.7 | 0.33 |
| RELA SRX7054663 | HAEC Cardiovascular | 177 / 9452 (1.9%) | 5827 / 94520 (6.2%) | −83.6 | −81.7 | 0.30 |
| RBFOX2 SRX3322781 | K-562 Blood | 1110 / 9452 (11.7%) | 5737 / 94520 (6.1%) | −83.6 | −81.7 | 1.93 |
| AR SRX9468654 | LNCAP Prostate | 228 / 9452 (2.4%) | 6655 / 94520 (7.0%) | −83.5 | −81.7 | 0.34 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 122 / 9452 (1.3%) | 4862 / 94520 (5.1%) | −83.4 | −81.5 | 0.25 |
| KAT7 DRX300414 | 293 Kidney | 355 / 9452 (3.8%) | 919 / 94520 (1.0%) | −83.3 | −81.4 | 3.86 |
| FOXA1 SRX6878606 | LNCAP Prostate | 94 / 9452 (1.0%) | 4333 / 94520 (4.6%) | −83.2 | −81.3 | 0.22 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 136 / 9452 (1.4%) | 5110 / 94520 (5.4%) | −83.1 | −81.3 | 0.27 |
| KMT2A SRX1293531 | MV-4-11 Blood | 1390 / 9452 (14.7%) | 7850 / 94520 (8.3%) | −83.1 | −81.2 | 1.77 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 362 / 9452 (3.8%) | 956 / 94520 (1.0%) | −83.1 | −81.2 | 3.79 |
| BRD4 SRX23813262 | C4-2B Prostate | 861 / 9452 (9.1%) | 3986 / 94520 (4.2%) | −83.0 | −81.2 | 2.16 |
| JUND SRX699738 | HCASMC Cardiovascular | 297 / 9452 (3.1%) | 7706 / 94520 (8.2%) | −83.0 | −81.1 | 0.39 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 204 / 9452 (2.2%) | 6247 / 94520 (6.6%) | −82.8 | −80.9 | 0.33 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 875 / 9452 (9.3%) | 4090 / 94520 (4.3%) | −82.8 | −80.9 | 2.14 |
| ESR1 SRX20282972 | MCF-7 Breast | 249 / 9452 (2.6%) | 6960 / 94520 (7.4%) | −82.7 | −80.8 | 0.36 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 383 / 9452 (4.1%) | 8963 / 94520 (9.5%) | −82.7 | −80.8 | 0.43 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 139 / 9452 (1.5%) | 5143 / 94520 (5.4%) | −82.6 | −80.7 | 0.27 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 415 / 9452 (4.4%) | 9413 / 94520 (10.0%) | −82.6 | −80.7 | 0.44 |
| FOXA1 SRX1885187 | LNCAP Prostate | 121 / 9452 (1.3%) | 4818 / 94520 (5.1%) | −82.6 | −80.7 | 0.25 |
| ESR1 SRX2943591 | MCF-7 Breast | 151 / 9452 (1.6%) | 5348 / 94520 (5.7%) | −82.5 | −80.6 | 0.28 |
| FOXA1 SRX1961158 | T-47D Breast | 209 / 9452 (2.2%) | 6315 / 94520 (6.7%) | −82.5 | −80.6 | 0.33 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 199 / 9452 (2.1%) | 6154 / 94520 (6.5%) | −82.5 | −80.6 | 0.32 |
| ARID1A SRX5679787 | 12Z Others | 74 / 9452 (0.8%) | 3920 / 94520 (4.1%) | −82.4 | −80.5 | 0.19 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 316 / 9452 (3.3%) | 7970 / 94520 (8.4%) | −82.4 | −80.5 | 0.40 |
| FOXA1 SRX1885188 | LNCAP Prostate | 155 / 9452 (1.6%) | 5411 / 94520 (5.7%) | −82.3 | −80.5 | 0.29 |
| FOXA1 SRX1961157 | T-47D Breast | 228 / 9452 (2.4%) | 6617 / 94520 (7.0%) | −82.3 | −80.4 | 0.34 |
| NR3C1 SRX2609666 | HASM2 Lung | 206 / 9452 (2.2%) | 6255 / 94520 (6.6%) | −82.1 | −80.2 | 0.33 |
| FOXA1 SRX9604646 | LNCAP Prostate | 289 / 9452 (3.1%) | 7552 / 94520 (8.0%) | −82.1 | −80.2 | 0.38 |
| ESR1 SRX371475 | BT-474 Breast | 103 / 9452 (1.1%) | 4473 / 94520 (4.7%) | −82.1 | −80.2 | 0.23 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 256 / 9452 (2.7%) | 7046 / 94520 (7.5%) | −82.1 | −80.2 | 0.36 |
| JUN SRX7277180 | GM07492 Others | 177 / 9452 (1.9%) | 5777 / 94520 (6.1%) | −82.1 | −80.2 | 0.31 |
| CXXC1 SRX1424886 | SEM Blood | 793 / 9452 (8.4%) | 3547 / 94520 (3.8%) | −82.0 | −80.2 | 2.24 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 147 / 9452 (1.6%) | 5259 / 94520 (5.6%) | −81.9 | −80.1 | 0.28 |
| FOXA1 SRX8537736 | MCF-7 Breast | 64 / 9452 (0.7%) | 3698 / 94520 (3.9%) | −81.9 | −80.0 | 0.17 |
| Epitope tags SRX1457740 | 293 Kidney | 517 / 9452 (5.5%) | 1812 / 94520 (1.9%) | −81.8 | −80.0 | 2.85 |
| CTCF SRX12008351 | MCF 10A Breast | 1585 / 9452 (16.8%) | 9415 / 94520 (10.0%) | −81.8 | −79.9 | 1.68 |
| DAXX SRX1021630 | PC-3 Prostate | 218 / 9452 (2.3%) | 6436 / 94520 (6.8%) | −81.7 | −79.8 | 0.34 |
| FLI1 SRX9738674 | A-673 Bone | 210 / 9452 (2.2%) | 6302 / 94520 (6.7%) | −81.6 | −79.8 | 0.33 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 419 / 9452 (4.4%) | 1267 / 94520 (1.3%) | −81.6 | −79.7 | 3.31 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 128 / 9452 (1.4%) | 71 / 94520 (0.1%) | −81.4 | −79.6 | 18.03 |
| TEAD1 SRX716558 | SF268 Neural | 100 / 9452 (1.1%) | 4396 / 94520 (4.7%) | −81.4 | −79.6 | 0.23 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 129 / 9452 (1.4%) | 4927 / 94520 (5.2%) | −81.3 | −79.5 | 0.26 |
| CDT1 SRX10644243 | HCT 116 Digestive tract | 892 / 9452 (9.4%) | 4240 / 94520 (4.5%) | −81.2 | −79.4 | 2.10 |
| TP53 SRX396254 | Fibroblasts Others | 472 / 9452 (5.0%) | 1563 / 94520 (1.7%) | −81.2 | −79.3 | 3.02 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 222 / 9452 (2.3%) | 6480 / 94520 (6.9%) | −81.1 | −79.3 | 0.34 |
| Epitope tags SRX3657345 | 293 Kidney | 1284 / 9452 (13.6%) | 7105 / 94520 (7.5%) | −81.1 | −79.2 | 1.81 |
| FOXA1 SRX3931032 | MCF-7 Breast | 120 / 9452 (1.3%) | 4753 / 94520 (5.0%) | −81.0 | −79.1 | 0.25 |
| FOXA1 SRX2642367 | VCaP Prostate | 175 / 9452 (1.9%) | 5707 / 94520 (6.0%) | −81.0 | −79.1 | 0.31 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 142 / 9452 (1.5%) | 5143 / 94520 (5.4%) | −81.0 | −79.1 | 0.28 |
| PHF6 SRX11508321 | G-401 Kidney | 837 / 9452 (8.9%) | 3868 / 94520 (4.1%) | −80.9 | −79.1 | 2.16 |
| JUNB SRX10119383 | MCF 10A Breast | 151 / 9452 (1.6%) | 5296 / 94520 (5.6%) | −80.9 | −79.1 | 0.29 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 138 / 9452 (1.5%) | 5073 / 94520 (5.4%) | −80.9 | −79.0 | 0.27 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 148 / 9452 (1.6%) | 5247 / 94520 (5.6%) | −80.9 | −79.0 | 0.28 |
| GATA2 SRX150427 | HUVEC Cardiovascular | 112 / 9452 (1.2%) | 4599 / 94520 (4.9%) | −80.8 | −78.9 | 0.24 |
| ASCL1 SRX8949802 | Unclassified Unclassified | 975 / 9452 (10.3%) | 4834 / 94520 (5.1%) | −80.8 | −78.9 | 2.02 |
| Epitope tags SRX4892334 | 293 Kidney | 1285 / 9452 (13.6%) | 7121 / 94520 (7.5%) | −80.7 | −78.9 | 1.80 |
| FOXA1 SRX9604645 | LNCAP Prostate | 302 / 9452 (3.2%) | 7699 / 94520 (8.1%) | −80.7 | −78.9 | 0.39 |
| AR SRX1067071 | LHSAR Prostate | 436 / 9452 (4.6%) | 9634 / 94520 (10.2%) | −80.6 | −78.8 | 0.45 |
| GATA3 SRX11150129 | Breast cancer cells Breast | 300 / 9452 (3.2%) | 7655 / 94520 (8.1%) | −80.4 | −78.6 | 0.39 |
| HOXC5 SRX2731653 | PC-3 Prostate | 169 / 9452 (1.8%) | 5591 / 94520 (5.9%) | −80.4 | −78.6 | 0.30 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 401 / 9452 (4.2%) | 9130 / 94520 (9.7%) | −80.4 | −78.6 | 0.44 |
| RUNX1 SRX10119135 | MV-4-11 Blood | 231 / 9452 (2.4%) | 6593 / 94520 (7.0%) | −80.3 | −78.5 | 0.35 |
| Epitope tags SRX15939724 | RD Muscle | 182 / 9452 (1.9%) | 5799 / 94520 (6.1%) | −80.3 | −78.4 | 0.31 |
| FOXA1 SRX8537737 | MCF-7 Breast | 73 / 9452 (0.8%) | 3835 / 94520 (4.1%) | −80.2 | −78.4 | 0.19 |
| FOXA1 SRX17794365 | VCaP Prostate | 101 / 9452 (1.1%) | 4378 / 94520 (4.6%) | −80.1 | −78.3 | 0.23 |
| CEBPB SRX4394545 | SU-DHL-1 Bone | 216 / 9452 (2.3%) | 6344 / 94520 (6.7%) | −80.1 | −78.3 | 0.34 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 123 / 9452 (1.3%) | 64 / 94520 (0.1%) | −80.0 | −78.2 | 19.22 |
| NR3C1 SRX17639412 | A549 Lung | 237 / 9452 (2.5%) | 6676 / 94520 (7.1%) | −80.0 | −78.2 | 0.36 |
| ZFX SRX7805370 | 293 Kidney | 629 / 9452 (6.7%) | 2523 / 94520 (2.7%) | −79.9 | −78.1 | 2.49 |
| CEBPB SRX2194250 | SUM 159PT Breast | 272 / 9452 (2.9%) | 7208 / 94520 (7.6%) | −79.8 | −78.0 | 0.38 |
| SMARCA4 SRX5982341 | A549 Lung | 58 / 9452 (0.6%) | 3510 / 94520 (3.7%) | −79.8 | −77.9 | 0.17 |
| JUN SRX4192884 | MCF 10A Breast | 190 / 9452 (2.0%) | 5913 / 94520 (6.3%) | −79.7 | −77.9 | 0.32 |
| EP300 SRX717859 | HeLa Uterus | 109 / 9452 (1.2%) | 4510 / 94520 (4.8%) | −79.7 | −77.8 | 0.24 |
| AR SRX9468663 | LNCAP Prostate | 245 / 9452 (2.6%) | 6785 / 94520 (7.2%) | −79.6 | −77.8 | 0.36 |
| ESR1 SRX10365533 | MCF-7 Breast | 98 / 9452 (1.0%) | 4296 / 94520 (4.5%) | −79.3 | −77.5 | 0.23 |
| FOXA1 SRX1787654 | MCF-7 Breast | 70 / 9452 (0.7%) | 3751 / 94520 (4.0%) | −79.3 | −77.5 | 0.19 |
Showing first 500 of 15713 rows.